RE: Back to sleepThe very important decision of picking the target cancer or a related cancer type for trial is what they must do next, as Bryden related at AGM. The Pharma interest is also a very time sensitive issue, and it will hopefullly develop to be between competing Pharma co's for Gap The selling action today could be for many reasons, ie: in at .11 last year, out today, etc... who cares. Steady pace of planned developments and being reported continually is going to move sp around and up via new buyers interest, BUT #1 and #2 will take sp much higher quickly. It's coming, be patient, enjoy your summer time.IMHO.